XML 41 R27.htm IDEA: XBRL DOCUMENT v3.24.1.u1
Stock award plan - (Tables)
3 Months Ended
Mar. 31, 2024
Share-based Payment Arrangement [Abstract]  
Summary of stock option activity

    

    

    

Weighted-

    

  

Weighted-

average

Aggregate

average

remaining

intrinsic

Number of

exercise

contractual

value(in 

options

price

term

thousands)

 

Outstanding at December 31, 2023

 

9,600,399

$

43.59

 

  

 

  

Granted

 

855,385

$

25.69

 

  

 

  

Exercised

 

(109,892)

$

19.22

 

  

 

  

Forfeited/Cancelled

 

(815,707)

$

45.32

 

  

 

  

Outstanding at March 31, 2024

 

9,530,185

$

42.12

 

5.90

years

$

12,025

Vested or Expected to vest at March 31, 2024

 

2,112,348

$

38.57

 

8.67

years

$

2,949

Exercisable at March 31, 2024

 

7,173,552

$

43.44

 

4.98

years

$

8,598

Schedule of assumptions used to estimate fair values of grants made on the date of grant

    

Three months ended

    

    

March 31, 2024

    

Risk-free interest rate

 

4.23%

 

Expected volatility

 

53%

 

Expected term

 

5.5 years

 

Summary of information on the Company's restricted stock

Restricted Stock Awards and Units

Weighted

Average

Grant

Number of

Date

    

Shares

    

Fair Value

Unvested at December 31, 2023

2,866,270

$

41.82

Granted

 

1,785,660

25.69

Vested

 

(835,179)

44.56

Forfeited

 

(86,585)

40.98

Unvested at March 31, 2024

 

3,730,166

$

33.51

Schedule of share-based compensation expense recorded in the statement of operations

Three Months Ended March 31, 

    

2024

    

2023

    

Research and development

$

8,967

$

15,314

Selling, general and administrative

 

9,411

 

13,501

Total

$

18,378

$

28,815